CLDI · Calidi Biotherapeutics, Inc. · Documents
$0.75
-0.02 (-2.55%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company estimates that based on the Company's liquidity resources, there is substantial doubt about the Company's ability to continue as a going concern within 12 months from the date of issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.99M
Shares
2.58M
Volume · Oct 21
54.89K
Avg daily vol (57 sessions)
151.84K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-09-25 | 2026-09-21 | |
| 8-K | — | 2026-09-22 | 2026-09-17 | |
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-08-13 | — | |
| 8-K | — | 2026-07-31 | 2026-07-27 | |
| 8-K | — | 2026-07-16 | 2026-07-10 | |
| 8-K | — | 2026-06-23 | 2026-06-17 | |
| 8-K | — | 2026-06-18 | 2026-06-12 | |
| DEFA14A | — | 2026-06-05 | — | |
| 8-K | — | 2026-05-29 | 2026-05-28 | |
| 8-K | — | 2026-05-14 | — | |
| 10-Q | — | 2026-05-14 | 2026-03-31 | |
| 8-K | — | 2026-05-08 | 2026-05-06 | |
| DEFA14A | — | 2026-04-29 | — | |
| DEF 14A | — | 2026-04-29 | — | |
| PRE 14A | — | 2026-04-17 | — | |
| 8-K | — | 2026-04-02 | 2026-03-29 | |
| 8-K | — | 2026-03-27 | — | |
| 10-K | — | 2026-03-27 | 2025-12-31 | |
| 8-K | — | 2026-03-11 | 2026-03-05 | |
| 8-K | — | 2026-02-10 | 2026-02-06 | |
| 8-K | — | 2026-01-29 | 2026-01-28 | |
| 8-K | — | 2025-11-13 | — | |
| 10-Q | — | 2025-11-13 | 2025-09-30 | |
| 8-K | — | 2025-11-10 | 2025-11-07 | |
| Investor Event Transcript | — | 2025-11-07 | 2025-12-31 | |
| 8-K | — | 2025-10-31 | 2025-10-27 | |
| 8-K | — | 2025-10-24 | 2025-10-22 | |
| 8-K | — | 2025-09-19 | 2025-08-08 | |
| 8-K | — | 2025-08-29 | — | |
| 8-K | — | 2025-08-22 | 2025-08-20 | |
| S-1 | — | 2025-08-15 | — | |
| 8-K | — | 2025-08-14 | 2025-08-08 | |
| 10-Q | — | 2025-08-08 | 2025-06-30 | |
| 8-K | — | 2025-08-08 | — | |
| 8-K | — | 2025-08-07 | 2025-08-04 | |
| 8-K | — | 2025-07-25 | 2025-07-24 | |
| S-3 | — | 2025-07-18 | — | |
| 8-K | — | 2025-07-11 | 2025-07-09 | |
| 8-K | — | 2025-07-10 | 2025-07-09 | |
| S-1 | — | 2025-07-03 | — | |
| DEF 14A | — | 2025-05-23 | — | |
| DEFA14A | — | 2025-05-23 | — | |
| 8-K | — | 2025-05-14 | — | |
| 10-Q | — | 2025-05-14 | 2025-03-31 | |
| PRE 14A | — | 2025-05-12 | — | |
| 8-K | — | 2025-05-02 | 2025-04-30 | |
| 8-K | — | 2025-04-23 | 2025-04-17 | |
| 8-K | — | 2025-04-10 | 2025-04-08 | |
| 8-K | — | 2025-04-01 | 2025-03-28 |
Showing 1–50 of 166 filings